E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/30/2005 in the Prospect News Biotech Daily.

Abbott subsidiaries get $1.9 billion in credit facilities

By Sara Rosenberg

New York, Nov. 30 - Eight of Abbott Laboratories' direct or indirect wholly owned subsidiaries entered into 30-month credit facilities with various lenders that, in the aggregate, permit borrowings of up to $1.9 billion, according to an 8-K filed with the Securities and Exchange Commission Wednesday.

Borrowings under the facilities will be used for general corporate purposes, including repatriation of funds under the American Jobs Creation Act of 2004.

The facilities closed on Nov. 23.

Abbott is an Abbott Park, Ill.-based health care products company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.